Five young mothers in Kota died within twelve days after a routine oxytocin shot. The vials meant to stop bleeding after childbirth had no drug in them at all, just water. What followed was an investigation that tore open a Punjab manufacturer's records: fabricated test data, tampered machines, missing safety checks, and a company that had been ordered to stop production three years ago and simply ignored it. Reported by Teena Thacker narrated by Anirban Chowdhury this epiosde traces the deaths, the daily-wage families left behind, and how a tiny, poorly regulated oxytocin market let a repeat offender keep supplying hospitals until it turned fatal.

Listen in.

You can follow Anirban Chowdhury on his social media: X and Linkedin and follow Teena Thacker on X and Linkedin

Check out other interesting episodes like:ET Deep Dive: Swipe Left on Reality,India wants manufacturing at 25% of GDP — will AI in factories help?, Tanay Kothari Wants To Kill The Keyboard,From Doer to Director: The LinkedIn Playbook for the AI Agea, Semaglutide Goes Generic: Big Pharma’s Moat Breaks  and much more.

Catch the latest episode of ‘The Morning Brief’ on The Economic Times Online, Spotify, Apple Podcasts, JioSaavn, Amazon Music and Youtube.

Five young mothers in Kota died within twelve days after a routine oxytocin shot. The vials meant to stop bleeding after childbirth had no drug in them at all, just water. What followed was an investigation that tore open a Punjab manufacturer's records: fabricated test data, tampered machines, missing safety checks, and a company that had been ordered to stop production three years ago and simply ignored it. Reported by Teena Thacker narrated by Anirban Chowdhury this epiosde traces the deaths, the daily-wage families left behind, and how a tiny, poorly regulated oxytocin market let a repeat offender keep supplying hospitals until it turned fatal. Listen in. You can follow Anirban Chowdhury on his social media:<a href="https://twitter.com/AnirbanET"> X</a> and<a href="https://www.linkedin.com/in/anirban-chowdhury-b5067219/"> Linkedin</a> and follow Teena Thacker on <a href="https://twitter.com/Teensthack">X</a> and <a href="https://www.linkedin.com/in/teena-thacker-b813b810">Linkedin </a>Check out other interesting episodes like:<a href="https://podcasts.apple.com/in/podcast/et-deep-dive-swipe-left-on-reality/id1568661777?i=1000763614435&amp;l=te">ET Deep Dive: Swipe Left on Reality</a>,<a href="https://podcasts.apple.com/in/podcast/india-wants-manufacturing-at-25-of-gdp-will-ai-in/id1568661777?i=1000760758322">India wants manufacturing at 25% of GDP &mdash; will AI in factories help?</a>, <a href="https://podcasts.apple.com/us/podcast/tanay-kothari-wants-to-kill-the-keyboard/id1568661777?i=1000758892178">Tanay Kothari Wants To Kill The Keyboard</a>,<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000738205536"> </a><a href="https://podcasts.apple.com/in/podcast/from-doer-to-director-the-linkedin-playbook-for-the-ai-age/id1568661777?i=1000756242616">From Doer to Director: The LinkedIn Playbook for the AI Agea</a>, <a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777?i=1000756051799">Semaglutide Goes Generic: Big Pharma&rsquo;s Moat Breaks</a>&nbsp; and<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777"> much more</a>.
Catch the latest episode of &lsquo;The Morning Brief&rsquo; on<a href="https://economictimes.indiatimes.com/podcast?from=mdr"> The Economic Times Online</a>,<a href="https://open.spotify.com/show/6PL5kfPbwURBEu6fHCVTOL?si=26ec0fbfa7134fea"> Spotify</a>,<a href="https://podcasts.apple.com/in/podcast/the-morning-brief/id1568661777"> Apple Podcasts</a>,<a href="https://www.jiosaavn.com/shows/the-morning-brief/1/GNPiFQD2xpY_"> JioSaavn</a>,<a href="https://music.amazon.in/podcasts/f378141f-9afb-495d-83da-9b08ec5047ac/the-morning-brief"> Amazon Music</a> and<a href="https://www.youtube.com/@theetpodcasts"> Youtube</a>.

To make sense of the week’s hottest stories in business, economy, politics and markets, journalists from the Economic Times chat with reporters and industry leaders in this thrice-weekly (Tuesday, Thursday, Friday) podcast.